Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$15,500.00
Jun 2, 2025
For-profit organization
YOUTH - Improvement of Therapeutic Delivery
1032999
This project focusses on developing a solution to stabilize a cryo-preserved therapy for atrial fibrillation (AF) at room temperature using established preservation techniques. This effort seeks to retain the therapy's biological properties, potentially resulting in scalable and cost-effective AF treatments that improve accessibility in emergency and outpatient settings.
$30,000.00
Jun 1, 2025
For-profit organization
YOUTH - Preclinical Research Scientist – Cardiac Models and Therapeutics
1032998
This project investigates the use of cardiac-derived biological particles as a novel, non-invasive therapy for atrial inflammation in a rat model that mimics postoperative atrial fibrillation. The particles will be administered and assessed for targeted uptake by heart tissue. The ultimate aim is to demonstrate that this approach can prevent atrial fibrosis and halt the progression of atrial fibrillation.